Top Markets
Coin of the day
RBC Bioscience Corporation RBC Bioscience Corporation

RBC Bioscience Corporation

6848
Rank in Stocks #32479
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Share Price
$0.69957862
Market Cap
$9.99M
Change (1 day)
-0.90%
Change (1 year)
18.70%
Country
TW
Trade RBC Bioscience Corporation (6848)

Category

P/S ratio for RBC Bioscience Corporation (6848)
P/S ratio as of 2026 TTM: 0
According to RBC Bioscience Corporation latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for RBC Bioscience Corporation from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE